Company Filing History:
Years Active: 2025
Title: Innovations of Tongyu Lin in Monoclonal Antibody Development
Introduction
Tongyu Lin is a prominent inventor based in Chengdu, China, known for his contributions to the field of immunology. He has developed significant innovations, particularly in the area of monoclonal antibodies, which have important applications in medical diagnostics and treatment.
Latest Patents
Tongyu Lin holds 2 patents, one of which is focused on an anti-CD79B protein monoclonal antibody. This invention includes a heavy chain and a light chain, with the heavy chain comprising a heavy chain variable region and the light chain containing a light chain variable region. The heavy chain variable region features complementary-determining regions CDR1, CDR2, and CDR3 with specific amino acid sequences. Similarly, the light chain variable region also comprises complementary-determining regions with designated amino acid sequences. This anti-CD79B protein monoclonal antibody is characterized by its high specificity and sensitivity, allowing for the precise recognition of cells expressing the CD79B protein. It is particularly suitable for immunological detection, significantly reducing the chances of false-positive and false-negative results in assays, thereby enhancing diagnostic accuracy.
Career Highlights
Tongyu Lin is affiliated with the Sichuan Cancer Hospital, where he applies his expertise in developing innovative solutions for cancer diagnostics and treatment. His work has been instrumental in advancing the understanding and application of monoclonal antibodies in clinical settings.
Collaborations
Tongyu Lin collaborates with notable colleagues, including Yang Liu and Zongyao Huang, contributing to a dynamic research environment focused on cancer treatment innovations.
Conclusion
Tongyu Lin's contributions to the field of monoclonal antibodies exemplify the impact of innovative research in improving medical diagnostics and treatment options. His work continues to influence the landscape of immunology and cancer care.